Drug Profile
Sym 013
Alternative Names: Sym013Latest Information Update: 07 Jun 2023
Price :
$50
*
At a glance
- Originator Symphogen
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Epidermal growth factor receptor antagonists; ERBB 2 receptor antagonists; ERBB-3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer